当前位置： SCI文献检索 > INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS期刊下所有文献 > In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

Abstract：

:The bactericidal activity and resistance selectivity of garenoxacin against Streptococcus pneumoniae with mutations in ParC (S79F) or both GyrA (S81F) and ParC (D83Y and K137N) were investigated using in vitro pharmacokinetic models simulating plasma concentrations for a standard clinical regimen [400mg once daily (q.d.)]. The efficacy of garenoxacin was compared with that of levofloxacin (500 mg q.d.) and moxifloxacin (400mg q.d.). Garenoxacin showed excellent bactericidal activity against S. pneumoniae, including quinolone-resistant S. pneumoniae (QRSP), achieving ratios of area under the plasma concentration-time curve over 24h to minimum inhibitory concentration (AUC(0-24)/MIC) ≥ 26.3, without emerging resistant subpopulations. The area above the killing curves was greater and the time to achieve 99.9% killing was shorter for garenoxacin than the corresponding values for levofloxacin and moxifloxacin. No resistant subpopulations and no additional substitution of amino acids in GyrA or ParC emerged following treatment with garenoxacin. On the other hand, in the parC mutant strain, levofloxacin and moxifloxacin treatment caused an increase in the frequency of the resistant population and an additional substitution of amino acids in GyrA (levofloxacin, S81Y/F/C; moxifloxacin, S81Y or E85K). In QRSP with mutations in GyrA and ParC, levofloxacin had no bactericidal activity, whilst the bactericidal activity of moxifloxacin was less than that of garenoxacin; moreover, an additional substitution of amino acids in ParC (S79Y) was noted. In conclusion, garenoxacin corresponding to an oral dose of 400mg showed excellent bactericidal activity against S. pneumoniae, including QRSP, without the emergence of resistant mutants.

journal_name

Int J Antimicrob Agents

journal_title

International journal of antimicrobial agents

authors

Fukuda Y,Takahata M,Sugiura Y,Shinmura Y,Nomura N

doi

10.1016/j.ijantimicag.2011.09.021

subject

Has Abstract

pub_date

2012-02-01 00:00:00

pages

163-7

issue

2

eissn

0924-8579

issn

1872-7913

pii

S0924-8579(11)00405-5

journal_volume

39

pub_type

杂志文章

相关文献

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS文献大全
  • New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better?

    abstract：:New initiatives have been introduced in Europe and the USA to encourage more rapid development of antibiotics. The need to ensure these new antibiotics can be safely used in children, and especially neonates, is important owing to high antimicrobial resistance in these patient groups. This review aims to determine wha...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/j.ijantimicag.2013.05.001

    authors： Garazzino S,Lutsar I,Bertaina C,Tovo PA,Sharland M

    更新日期：2013-08-01 00:00:00

  • Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.

    abstract：:The presence of the plasmid-mediated quinolone resistance determinants qnrA, qnrB, qnrS and aac(6')-Ib-cr was evaluated in a collection of 382 isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae collected between February and March 2006 for the nationwide Spanish GEIH-...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2011.12.009

    authors： Briales A,Rodríguez-Martínez JM,Velasco C,de Alba PD,Rodríguez-Baño J,Martínez-Martínez L,Pascual A

    更新日期：2012-05-01 00:00:00

  • Retrospective survey of mcr-1 and mcr-2 in German pig-fattening farms, 2011-2012.

    abstract：:In November 2015, the first plasmid-encoded colistin resistance gene, mcr-1, was described in animals and in humans in China. Subsequently, a multitude of further studies was performed and quite recently the global spread of mcr-1 as well as the occurrence of a new gene variant, mcr-2, was reported. To obtain an overv...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2017.03.007

    authors： Roschanski N,Falgenhauer L,Grobbel M,Guenther S,Kreienbrock L,Imirzalioglu C,Roesler U

    更新日期：2017-08-01 00:00:00

  • Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone.

    abstract：:The tet(X) gene encodes a flavin-dependent monooxygenase that confers resistance to all clinically relevant tetracycline antibiotics including tigecycline. It has only previously been identified in environmental and non-human pathogenic bacteria. To investigate levels of multidrug resistance in Bo, Sierra Leone, a mol...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2013.04.014

    authors： Leski TA,Bangura U,Jimmy DH,Ansumana R,Lizewski SE,Stenger DA,Taitt CR,Vora GJ

    更新日期：2013-07-01 00:00:00

  • Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.

    abstract：:As a result of macrolide resistance rates of 25% for pneumococci in the US, the clinical use of this class as empirical therapy has been questioned. However, macrolides continue to be used with clinical success. Using an immunocompromised murine pneumonia model, this study evaluated in vivo efficacy of human simulated...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2003.09.028

    authors： Maglio D,Capitano B,Banevicius MA,Tessier PR,Nightingale CH,Nicolau DP

    更新日期：2004-05-01 00:00:00

  • suPAR: The unspecific marker for disease presence, severity and prognosis.

    abstract：:Investigation of biomarkers that can promptly predict unfavourable outcome of critically illness is an emerging necessity taking into consideration the need for early intervention, the shortage of available beds in intensive care units and the considerable cost of hospitalisation. The most promising biomarker is solub...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/j.ijantimicag.2015.10.011

    authors： Eugen-Olsen J,Giamarellos-Bourboulis EJ

    更新日期：2015-12-01 00:00:00

  • Lipid-based amphotericin B: a review of the last 10 years of use.

    abstract：:The last decade has been remarkable for the dramatic increase in the prevalence of serious fungal infections in patients with haematological disorders and neutropenic cancer patients. The mortality rate of deep-seated infection has been in excess of 90% and there is no doubt that this is one of the greatest challenges...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/s0924-8579(00)00341-1

    authors： Hann IM,Prentice HG

    更新日期：2001-03-01 00:00:00

  • Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.

    abstract：:This study aimed to forecast the incidence rate of carbapenem resistance and to assess the impact of an antimicrobial stewardship intervention using routine antimicrobial consumption surveillance data. Following an outbreak of OXA-48-producing Klebsiella pneumoniae (January 2008-April 2010) in a renal cohort in London...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2015.03.005

    authors： Gharbi M,Moore LS,Gilchrist M,Thomas CP,Bamford K,Brannigan ET,Holmes AH

    更新日期：2015-08-01 00:00:00

  • Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.

    abstract：:The activity of eight aminoglycosides (amikacin, apramycin, arbekacin, gentamicin, kanamycin, neomycin, netilmicin and tobramycin) against a collection of 257 amoxicillin/clavulanic acid (AMC)-resistant Escherichia coli isolates was determined by microdilution. Aminoglycoside resistance rates, the prevalence of aminog...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.ijantimicag.2015.03.008

    authors： Fernández-Martínez M,Miró E,Ortega A,Bou G,González-López JJ,Oliver A,Pascual A,Cercenado E,Oteo J,Martínez-Martínez L,Navarro F,Spanish Network for the Research in Infectious Diseases (REIPI).

    更新日期：2015-08-01 00:00:00

  • Antibacterial activity of high concentrations of carvedilol against Gram-positive and Gram-negative bacteria.

    abstract：:Many drugs used to treat non-infectious diseases have also shown excellent antibacterial activity or the ability to enhance the action of antibiotics. The aim of this study was to investigate the antibacterial activity of a popular β-blocker, carvedilol, and its mechanism of antibacterial action. The antibacterial act...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2017.12.014

    authors： Zawadzka K,Bernat P,Felczak A,Różalska S,Lisowska K

    更新日期：2018-03-01 00:00:00

  • Antifungal activities of azole agents against the Malassezia species.

    abstract：:In this paper, we identified 95 Malassezia isolates by morphological and biochemical criteria and assessed the in vitro activity of fluconazole, itraconazole, ketoconazole and voriconazole by broth microdilution against these species using slightly modified Leeming-Notman medium. The Malassezia isolates were identifie...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2006.09.016

    authors： Miranda KC,de Araujo CR,Costa CR,Passos XS,de Fátima Lisboa Fernandes O,do Rosário Rodrigues Silva M

    更新日期：2007-03-01 00:00:00

  • Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils.

    abstract：:It has been previously demonstrated that some antimicrobial agents enhance activities of human polymorphonuclear neutrophils (PMNs). The effect on the release of cytokines in an inflammatory context from PMNs by these antibiotics was evaluated. We studied the effect of the release of some cytokines by human PMNs RT-PC...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2003.07.006

    authors： Reato G,Cuffini AM,Tullio V,Mandras N,Roana J,Banche G,Foa R,Carlone NA

    更新日期：2004-02-01 00:00:00

  • In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.

    abstract：:We investigated the in vitro activity of various piperacillin and sulbactam combinations against Gram-negative bacterial isolates from Intensive Care Units (ICUs) in Taiwan. Antimicrobial susceptibility testing of 1030 bacterial isolates recovered from ICUs of nine major teaching hospitals was performed using the agar...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2006.02.017

    authors： Hung MN,Hsueh PR,Chang HT,Lee WS,Chou MY,Chen IS,Wang JH,Lin CF,Shyr JM,Ko WC,Wu JJ,Liu YC,Huang WK,Teng LJ,Liu CY,Luh KT

    更新日期：2007-02-01 00:00:00

  • 'To bead or not to bead?' Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains.

    abstract：:Gentamicin-containing polymethylmethacrylate (PMMA) beads are frequently used to prevent and treat orthopaedic infections. The beads are typically inserted to fill anatomical defects secondary to surgical debridement. Local gentamicin use results in low serum levels whilst achieving high concentrations at the site of ...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/j.ijantimicag.2011.03.008

    authors： Barth RE,Vogely HC,Hoepelman AI,Peters EJ

    更新日期：2011-11-01 00:00:00

  • Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.

    abstract：:Advanced molecular typing methods have greatly expanded the taxonomy of Mycobacterium avium complex (MAC) species; however, little is known about the epidemiology and clinical features of bacteraemia caused by different MAC species. In this study, the clinical characteristics of patients treated for MAC bacteraemia in...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2017.02.016

    authors： Lee MR,Chien JY,Huang YT,Liao CH,Shu CC,Yu CJ,Hsueh PR

    更新日期：2017-07-01 00:00:00

  • Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.

    abstract：:From January through June of 1998, 4579 bloodstream infections (BSI) due to bacterial pathogens were reported from SENTRY hospitals in Canada, the USA and Latin America. Staphylococcus aureus, Escherichia coli, and coagulase-negative staphylococcus (CoNS) were the most common pathogens, together accounting for 55.2% o...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/s0924-8579(99)00131-4

    authors： Diekema DJ,Pfaller MA,Jones RN,Doern GV,Kugler KC,Beach ML,Sader HS

    更新日期：2000-02-01 00:00:00

  • Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?

    abstract：:Macrolide monotherapy is currently recommended as first-line treatment of mild-to-moderate community-acquired pneumonia (CAP) in penicillin-intolerant/allergic individuals in the UK. However, resistance rates among the commonest cause, Streptococcus pneumoniae, now exceed 10% in the UK and a review of alternative agen...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/j.ijantimicag.2008.02.003

    authors： Ludlam HA,Enoch DA

    更新日期：2008-08-01 00:00:00

  • Investigations into the in vitro antimicrobial activity and mode of action of the phenazine antibiotic D-alanylgriseoluteic acid.

    abstract：:D-Alanylgriseoluteic acid (AGA) is a potent antimicrobial phenazine compound produced by Pantoea agglomerans (Erwinia herbicola) Eh1087. Susceptibility tests against a range of microbes indicated that AGA had a broad spectrum of antimicrobial activity and was particularly active against Gram-positive pathogens. Compar...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2006.08.028

    authors： Giddens SR,Bean DC

    更新日期：2007-01-01 00:00:00

  • Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications.

    abstract：:Acinetobacter baumannii has emerged as a major pathogen causing nosocomial infections, particularly in critical patients admitted to the Intensive Care Unit. Increasing resistance to carbapenems in A. baumannii has been observed worldwide. Here we report the clinical impact and mechanism of imipenem heteroresistance (...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2010.12.015

    authors： Lee HY,Chen CL,Wang SB,Su LH,Chen SH,Liu SY,Wu TL,Lin TY,Chiu CH

    更新日期：2011-04-01 00:00:00

  • Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.

    abstract：:Fluoroquinolone (FQ) resistance is usually caused by point mutations within the quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and/or parE. However, little is known about the worldwide increase in FQ-resistant Escherichia coli or, more specifically, about the geographical distribution of QRDR mut...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2009.12.005

    authors： Uchida Y,Mochimaru T,Morokuma Y,Kiyosuke M,Fujise M,Eto F,Harada Y,Kadowaki M,Shimono N,Kang D

    更新日期：2010-04-01 00:00:00

  • The burden of invasive pneumococcal disease and the potential for reduction by immunisation.

    abstract：:Streptococcus pneumoniae causes invasive disease world-wide and in all age groups. The reported incidence varies geographically and is increased in certain population groups. The incidence is highest in children less than 2 years and is also increased in the elderly. Mortality remains substantial even in the developed...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/s0924-8579(01)00491-5

    authors： Parsons HK,Dockrell DH

    更新日期：2002-02-01 00:00:00

  • In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections.

    abstract：:The antimicrobial activity of linezolid, a recently developed antibiotic agent active against Gram-positive bacteria, was tested against pathogens from three different collections. (1) Uropathogens from hospitalized urological patients (1990/1991) with complicated and/or hospital-acquired UTIs; Urologic Clinic, Hospit...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/s0924-8579(01)00374-0

    authors： Onda H,Wagenlehner FM,Lehn N,Naber KG

    更新日期：2001-09-01 00:00:00

  • Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment.

    abstract：:Piperacillin-tazobactam (PIP-TAZ) is commonly used to treat intraabdominal infections; however, its penetration into abdominal sites is unclear. A pharmacokinetic analysis of plasma, peritoneal fluid, and peritoneum drug concentrations was conducted to simulate dosing regimens needed to attain the pharmacodynamic targ...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2017.03.025

    authors： Murao N,Ohge H,Ikawa K,Watadani Y,Uegami S,Shigemoto N,Shimada N,Yano R,Kajihara T,Uemura K,Murakami Y,Morikawa N,Sueda T

    更新日期：2017-09-01 00:00:00

  • Antimicrobial drug resistance in Taiwan.

    abstract：:Antimicrobial resistance is a major health problem worldwide, but marked variations in the resistance profiles of bacterial pathogens are found between countries and in different patient settings, especially in Asia. In Taiwan, the strikingly high prevalence of resistance to macrolides and streptogramins in clinical i...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章,评审

    doi：10.1016/S0924-8579(08)70023-2

    authors： Huang YT,Hsueh PR

    更新日期：2008-11-01 00:00:00

  • Survey of extended-spectrum beta-lactamases in Escherichia coli isolates from a Portuguese hospital and characterisation of a novel class 1 integron (In60A) carrying the blaCTX-M-9 gene.

    abstract：:Between November 2001 and November 2004, 231 Escherichia coli isolates resistant to beta-lactam antibiotics were identified. In 14 isolates, bla(TEM-24) (2 isolates), bla(TEM-52) (5 isolates) and bla(TEM-26) (7 isolates) were identified. In 145 E. coli isolates with the same M13 fingerprinting profile and the same res...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2006.08.002

    authors： Brizio A,Vasco S,Gonçalves AR,Lito LM,Cristino JM,Salgado MJ,Duarte A

    更新日期：2006-10-01 00:00:00

  • Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.

    abstract：:Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) bloodstream infections (BSIs) are related to high mortality rates, and combination therapy has been associated with lower mortality in patients treated mostly with colistin. There is a paucity of studies addressing polymyxin B (PMB) treatment for KPC...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2018.10.010

    authors： Medeiros GS,Rigatto MH,Falci DR,Zavascki AP

    更新日期：2019-02-01 00:00:00

  • Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis.

    abstract：:Antimicrobial peptides (AMPs) are essential host defence molecules found in a wide variety of species and are promising antibacterial therapeutic candidates. Focusing on the human cathelicidin peptide LL-37, the aim of the present study was to explore the mechanisms of action and antimicrobial activities of a library ...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2010.06.031

    authors： Kanthawong S,Bolscher JG,Veerman EC,van Marle J,Nazmi K,Wongratanacheewin S,Taweechaisupapong S

    更新日期：2010-11-01 00:00:00

  • Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.

    abstract：:Antimicrobial peptides (AMPs) are produced by all forms of living organisms and represent a novel class of antibiotics to treat infectious diseases. In this study, 29 AMPs of varying length and characteristics were synthesised chemically and were evaluated for their ability to inhibit the growth of Bacillus globigii, ...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2010.06.038

    authors： Dawson RM,McAllister J,Liu CQ

    更新日期：2010-10-01 00:00:00

  • Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces.

    abstract：:The antimicrobial activity against Clostridium difficile of 109 lactic acid bacteria (LAB) isolated from 32 healthy Korean infants was measured. The ability to show similar activity against Escherichia coli O157:H7 and Staphylococcus aureus was also looked for. Twelve of the 109 LAB showed activity against C. difficil...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/s0924-8579(02)00389-8

    authors： Lee YJ,Yu WK,Heo TR

    更新日期：2003-04-01 00:00:00

  • Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis.

    abstract：:Bacterial osteomyelitis is a major clinical challenge in human and veterinary patients. This infection is an infrequent but feared complication of orthopedic surgery and is mainly caused by methicillin-resistant Staphylococcus aureus (MRSA). The aim of this study was to evaluate the efficacy of dalbavancin (dosed for ...

    journal_title：International journal of antimicrobial agents

    pub_type： 杂志文章

    doi：10.1016/j.ijantimicag.2020.106021

    authors： Silva V,Miranda C,Antão HS,Guimarães J,Prada J,Pires I,Maltez L,Pereira JE,Capelo JL,Igrejas G,Poeta P

    更新日期：2020-07-01 00:00:00